Vaxcyte
Highly Engaged Employees
Highly Engaged EmployeesBlood & Organ Banks · California, United States · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
825 Industrial Rd Ste 300, San Carlos, C...Phone Number
(650) 837-0111Website
www.vaxcyte.comRevenue
-Stock Symbol
PCVXIndustry
ZI Rank: 11
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
8
13
22
15
15
11
About Vaxcyte
Vaxcyte is a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide. The company is headquartered in San Carlos, California.Explore more
Vaxcyte Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Vaxcyte your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Vaxcyte has new funding data
Check out if Vaxcyte is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Vaxcyte
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Vaxcyte recently announced quarterly report
Product Launch: Get notified when Vaxcyte launches new products
Click to see if Vaxcyte had a recent Job posting/layoffs
Check if Vaxcyte has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Vaxcyte, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Vaxcyte
Find 2 more new buyers
Compare Similar Companies to Vaxcyte
Compare insights from companies similar to Vaxcyte, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Vaxcyte is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Vaxcyte is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Vaxcyte.
Vaxcyte financials insights
Gather financial insights about Vaxcyte, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Series A
$22M
2017
Series B
$60M
Other Financing Round
$4M
2018
Series C
$85M
2020
Series D
$110M
2022
Stock Offering
$100M
2024
Share Placement
$750M
Vaxcyte Tech Stack
A closer look at the technologies used by Vaxcyte
Most Recent Scoops
Open Position
Open Position
Hiring Plans
Vaxcyte has more open roles in Engineering & Technical than it has had at any time in the past 12 months. Areas of expertise include: Mathematical Optimization, Data-Driven Decision Making, Mass Spectrometry, Performance Improvement, Analytical Testing, Analytical Techniques, and Corrective Action Management.
Hiring Plans
Open Position
Open Position
Vaxcyte News & Media
Vaxcyte to Participate in Upcoming Investor Conferences
SAN CARLOS, Calif., July 08, 2026 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company, today announced that Company management will participate in and host one-on-one meetings at the following investor conferences:Vaxcyte Inc (PCVX) Is A Hidden Multibagger Stock To Buy Now
Vaxcyte Inc. (NASDAQ:PCVX) is one of the 8 Hidden Multibagger Stocks to Buy Now. On June 18, Mizuho Securities analyst Salim Syed reiterated a Buy rating on Vaxcyte Inc. (NASDAQ:PCVX) with a price target of $163. The firm’s price target reflects a significant 180% upside from current levels. Earlier on June 16, PCVX announced an […]Vaxcyte (PCVX) Doses Its First Patient in a Trial for a Disease With No Existing Vaccine
Vaxcyte, Inc. (NASDAQ:PCVX) is one of the most promising healthcare stocks according to Wall Street analysts. On June 2, Vaxcyte, Inc. (NASDAQ:PCVX) dosed the first participant in its Phase 1 first-in-human clinical trial of VAX-A1. VAX-A1 is the company’s experimental vaccine against Group A Streptococcus, or Group A Strep. The dosing marks Vaxcyte’s entry of […]Vaxcyte Doses First Participant in Phase 1 Study Evaluating VAX-A1 for the Prevention of Disease Caused by Group A Streptococcus in Healthy Adults
First-in-Human Study Evaluating VAX-A1, a Potential Best-in-Class Vaccine Candidate Designed to Provide Broad Protection Against Disease Caused by Group A Streptococcus
Read more news
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Vaxcyte
Sign Up For FreeTo access detailed company insights
Vaxcyte is a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide. The company is headquartered in San Carlos, California.... Read More
